We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $85.1B
1-Year Est. Return 20.93%
This Fund
S&P 500
This Quarter Est. Return
-0.06%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$60.5B
AUM Growth
+$2.39B
Cap. Flow
+$1.77B
Cap. Flow %
2.93%
Top 10 Hldgs %
17.56%
Holding
4,827
New
882
Increased
1,455
Reduced
1,567
Closed
849

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$210M
2
UNH icon
UnitedHealth
UNH
+$158M
3
NFLX icon
Netflix
NFLX
+$140M
4
DG icon
Dollar General
DG
+$135M
5
MU icon
Micron Technology
MU
+$124M

Sector Composition

Rank Sector Weight
1 Technology 9.07%
2 Consumer Discretionary 6.01%
3 Healthcare 4.63%
4 Industrials 4.29%
5 Financials 4.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RJF icon
2901
Raymond James Financial
RJF
$34B
$625K ﹤0.01%
5,055
-47
-0.9% -$5.8K
ZYME icon
2902
Zymeworks
ZYME
$1.66B
$624K ﹤0.01%
73,324
+58,716
+402% +$523K
GTY
2903
Getty Realty Corp
GTY
$2.12B
$624K ﹤0.01%
23,396
-5,037
-18% -$137K
FSK icon
2904
FS KKR Capital
FSK
$3.08B
$623K ﹤0.01%
+31,581
New +$621K
ALL icon
2905
CALL
Allstate
ALL
$70.1B
$623K ﹤0.01%
3,900
-32,200
-89% -$5.37M
D icon
2906
CALL
Dominion Energy
D
$62.1B
$622K ﹤0.01%
12,700
-79,500
-86% -$4.05M
MYRG icon
2907
MYR Group
MYRG
$5.31B
$619K ﹤0.01%
+4,563
New +$713K
PODD icon
2908
Insulet
PODD
$11.6B
$619K ﹤0.01%
3,067
-81,072
-96% -$14.6M
PTVE
2909
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
$618K ﹤0.01%
54,555
-17,860
-25% -$238K
OLMA icon
2910
Olema Pharmaceuticals
OLMA
$1.01B
$617K ﹤0.01%
57,070
-16,519
-22% -$179K
CCO icon
2911
Clear Channel Outdoor Holdings
CCO
$1.23B
$617K ﹤0.01%
+437,515
New +$645K
ACA icon
2912
Arcosa
ACA
$7.13B
$614K ﹤0.01%
+7,363
New +$613K
AGEN
2913
Agenus
AGEN
$275M
$614K ﹤0.01%
+36,651
New +$443K
LIVN icon
2914
LivaNova
LIVN
$4.51B
$613K ﹤0.01%
11,173
+5,601
+101% +$319K
HEES
2915
DELISTED
H&E Equipment Services
HEES
$612K ﹤0.01%
+13,865
New +$711K
FDS icon
2916
CALL
Factset
FDS
$10.1B
$612K ﹤0.01%
1,500
-5,200
-78% -$2.21M
KNTK icon
2917
Kinetik
KNTK
$3.64B
$610K ﹤0.01%
14,729
+4,150
+39% +$165K
HCAT icon
2918
Health Catalyst
HCAT
$158M
$610K ﹤0.01%
95,463
-96,341
-50% -$618K
ZNTL icon
2919
Zentalis Pharmaceuticals
ZNTL
$329M
$608K ﹤0.01%
148,755
+125,649
+544% +$1.4M
CVLG icon
2920
Covenant Logistics
CVLG
$1.09B
$608K ﹤0.01%
24,654
-6,166
-20% -$143K
SAND
2921
DELISTED
Sandstorm Gold
SAND
$606K ﹤0.01%
+111,410
New +$616K
CLBT icon
2922
Cellebrite
CLBT
$3.7B
$606K ﹤0.01%
50,689
-30,659
-38% -$343K
FITB
2923
PUT
Fifth Third Bancorp
FITB
$52.4B
$606K ﹤0.01%
16,600
-7,100
-30% -$259K
SM icon
2924
PUT
SM Energy
SM
$7.11B
$605K ﹤0.01%
14,000
+6,900
+97% +$339K
LYB icon
2925
PUT
LyondellBasell Industries
LYB
$18.8B
$603K ﹤0.01%
6,300
-300
-5% -$29.8K

Similar funds

Squarepoint's Q2 2024 Portfolio in Review

As of Q2 2024, Squarepoint held 4,827 positions worth $60.5B, up 4.1% from $58.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Squarepoint's Q2 2024 filing shows 882 new, 1,455 increased, 1,567 reduced and 849 closed positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,286,013 shares worth $700M. The largest sale was Apple, an estimated $210M.

By sector, the portfolio is most concentrated in Technology at 9.1% of assets, up from 8.5% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Squarepoint's largest Q2 2024 buy was State Street SPDR S&P 500 ETF Trust: 1,286,013 shares worth $700M.
  • Squarepoint added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $1.29B increase.
  • Squarepoint's biggest Q2 2024 reduction was Apple, cutting an estimated $210M.
  • Squarepoint fully exited DraftKings in Q2 2024, selling an estimated $94.6M.
  • Squarepoint's ten largest holdings make up 18% of its $60.5B portfolio in Q2 2024.
  • Squarepoint opened 882 new positions and closed 849 in Q2 2024.
  • Squarepoint's portfolio value rose 4.1% quarter-over-quarter to $60.5B.

Based on Squarepoint's 13F filing for Q2 2024, filed 14 Aug 2024.